Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("REICHARDT, Juergen K. V")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Identification and characterization of somatic steroid 5α-reductase (SRD5A2) mutations in human prostate cancer tissueMAKRIDAKIS, Nick; AKALU, Abebe; REICHARDT, Juergen K. V et al.Oncogene (Basingstoke). 2004, Vol 23, Num 44, pp 7399-7405, issn 0950-9232, 7 p.Article

Multiplex automated primer extension analysis: Simultaneous genotyping of several polymorphismsMAKRIDAKIS, Nick M; REICHARDT, Juergen K. V.BioTechniques. 2001, Vol 31, Num 6, pp 1374-1380, issn 0736-6205Article

Hormones and prostate cancer: Current perspectives and future directionsHSING, Ann W; REICHARDT, Juergen K. V; STANCZYK, Frank Z et al.The Prostate. 2002, Vol 52, Num 3, pp 213-235, issn 0270-4137Article

Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British menALLEN, Naomi E; REICHARDT, Juergen K. V; NGUYEN, Hannah et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 6, pp 578-581, issn 1055-9965, 4 p.Article

Associations between polymorphisms in the steroid 5-α reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancerSALAM, Muhammad T; URSIN, Giske; SKINNER, Eila C et al.Urologic oncology. 2005, Vol 23, Num 4, pp 246-253, issn 1078-1439, 8 p.Article

Robustness of gene expression profiling in glioma specimen samplings and derived cell linesSHAI, Ruty Mehrian; REICHARDT, Juergen K. V; YA-HSUAN, Hsu et al.Molecular brain research. 2005, Vol 136, Num 1-2, pp 99-103, issn 0169-328X, 5 p.Article

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control studyHSING, Ann W; CHU CHEN; STANCZYK, Frank Z et al.Cancer epidemiology, biomarkers & prevention. 2001, Vol 10, Num 10, pp 1077-1082, issn 1055-9965Article

Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian menMARGIOTTI, Katia; KIM, Eugene; PEARCE, C. Leigh et al.The Prostate. 2002, Vol 53, Num 1, pp 65-68, issn 0270-4137Article

Androgen Receptor CAG Repeat Length and Association With Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialPRICE, Douglas K; CHAU, Cindy H; REICHARDT, Juergen K. V et al.The Journal of urology. 2010, Vol 184, Num 6, pp 2297-2302, issn 0022-5347, 6 p.Article

Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention TrialLI TANG; SONG YAO; REICHARDT, Juergen K. V et al.Carcinogenesis (New York. Print). 2011, Vol 32, Num 10, pp 1500-1506, issn 0143-3334, 7 p.Article

Molecular epidemiology of hormone-metabolic loci in prostate cancerMAKRIDAKIS, Nick M; REICHARDT, Juergen K. V.Epidemiologic reviews. 2001, Vol 23, Num 1, pp 24-29, issn 0193-936XArticle

A genetic factor for age-related cataract : Identification and characterization of a novel galactokinase variant, Osaka, in AsiansOKANO, Yoshiyuki; ASADA, Minoru; NIIHIRA, Shizuhiro et al.American journal of human genetics. 2001, Vol 68, Num 4, pp 1036-1042, issn 0002-9297Article

Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialFIGG, William D; CHAU, Cindy H; VAN BOKHOVEN, Adrie et al.Urology (Ridgewood, NJ). 2014, Vol 84, Num 1, pp 127-131, issn 0090-4295, 5 p.Article

No association between the SRD5A2 gene A49T missense variant and prostate cancer risk : lessons learnedPEARCE, C. Leigh; VAN DEN BERG, David J; MAKRIDAKIS, Nick et al.Human molecular genetics (Print). 2008, Vol 17, Num 16, pp 2456-2461, issn 0964-6906, 6 p.Article

Molecular epidemiology of androgen-metabolic loci in prostate cancer: Predisposition and progression. DiscussionMAKRIDAKIS, Nick M; REICHARDT, Juergen K. V; KLEIN, Eric et al.The Journal of urology. 2004, Vol 171, Num 2, pp S25-S29, issn 0022-5347, 2Conference Paper

Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancerGOODMAN, Marc T; WU, Anna H; TUNG, Ko-Hui et al.American journal of epidemiology. 2002, Vol 156, Num 8, pp 693-701, issn 0002-9262Article

Steroid 5-α reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population studyPEARCE, Celeste L; MAKRIDAKIS, Nick M; ROSS, Ronald K et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 4, pp 417-418, issn 1055-9965Article

  • Page / 1